Click for best price
Cell Gene Therapy Manufacturing QC Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing QC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing QC. This report contains market size and forecasts of Cell and Gene Therapy Manufacturing QC in global, including the following market information:
Global Cell and Gene Therapy Manufacturing QC Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cell and Gene Therapy Manufacturing QC market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Safety Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing QC include Bio-Techne Corporation, BioMerieux SA, Catalent, Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Intertek Group plc, Lonza Group AG and Merck KGaA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell and Gene Therapy Manufacturing QC companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing QC Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Manufacturing QC Market Segment Percentages, by Type, 2022 (%)
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing
Global Cell and Gene Therapy Manufacturing QC Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cell and Gene Therapy Manufacturing QC Market Segment Percentages, by Application, 2022 (%)
Precision Therapy
Biological Research
Global Cell and Gene Therapy Manufacturing QC Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cell and Gene Therapy Manufacturing QC Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing QC revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing QC revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy Manufacturing QC, market overview.
Chapter 2: Global Cell and Gene Therapy Manufacturing QC market size in revenue.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing QC company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy Manufacturing QC in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cell and Gene Therapy Manufacturing QC Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Manufacturing QC Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing QC Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing QC Overall Market Size
2.1 Global Cell and Gene Therapy Manufacturing QC Market Size: 2022 VS 2030
2.2 Global Cell and Gene Therapy Manufacturing QC Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Manufacturing QC Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing QC Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing QC Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing QC Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Manufacturing QC Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing QC Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Manufacturing QC Market Size Markets, 2022 & 2030
4.1.2 Safety Testing
4.1.3 Purity Testing
4.1.4 Potency Testing
4.1.5 Identity Testing
4.1.6 Stability Testing
4.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
4.2.3 By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Manufacturing QC Market Size, 2022 & 2030
5.1.2 Precision Therapy
5.1.3 Biological Research
5.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
5.2.3 By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Manufacturing QC Market Size, 2022 & 2030
6.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue, 2024-2030
6.2.3 By Region - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.3.2 US Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.4.2 Germany Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.3 France Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.4 U.K. Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.5 Italy Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.6 Russia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.4.8 Benelux Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.5.2 China Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.3 Japan Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.5.6 India Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.6.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.6.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030
6.7.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.3 Israel Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
6.7.5 UAE Cell and Gene Therapy Manufacturing QC Market Size, 2018-2030
7 Cell and Gene Therapy Manufacturing QC Companies Profiles
7.1 Bio-Techne Corporation
7.1.1 Bio-Techne Corporation Company Summary
7.1.2 Bio-Techne Corporation Business Overview
7.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.1.5 Bio-Techne Corporation Key News & Latest Developments
7.2 BioMerieux SA
7.2.1 BioMerieux SA Company Summary
7.2.2 BioMerieux SA Business Overview
7.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.2.5 BioMerieux SA Key News & Latest Developments
7.3 Catalent, Inc.
7.3.1 Catalent, Inc. Company Summary
7.3.2 Catalent, Inc. Business Overview
7.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.3.5 Catalent, Inc. Key News & Latest Developments
7.4 Charles River Laboratories International Inc.
7.4.1 Charles River Laboratories International Inc. Company Summary
7.4.2 Charles River Laboratories International Inc. Business Overview
7.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.4.5 Charles River Laboratories International Inc. Key News & Latest Developments
7.5 Eurofins Scientific SE
7.5.1 Eurofins Scientific SE Company Summary
7.5.2 Eurofins Scientific SE Business Overview
7.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.5.5 Eurofins Scientific SE Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Intertek Group plc
7.7.1 Intertek Group plc Company Summary
7.7.2 Intertek Group plc Business Overview
7.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.7.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.7.5 Intertek Group plc Key News & Latest Developments
7.8 Lonza Group AG
7.8.1 Lonza Group AG Company Summary
7.8.2 Lonza Group AG Business Overview
7.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.8.5 Lonza Group AG Key News & Latest Developments
7.9 Merck KGaA
7.9.1 Merck KGaA Company Summary
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.9.5 Merck KGaA Key News & Latest Developments
7.10 Sartorius AG
7.10.1 Sartorius AG Company Summary
7.10.2 Sartorius AG Business Overview
7.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.10.5 Sartorius AG Key News & Latest Developments
7.11 SGS S.A.
7.11.1 SGS S.A. Company Summary
7.11.2 SGS S.A. Business Overview
7.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.11.5 SGS S.A. Key News & Latest Developments
7.12 Sistemic Scotland Limited
7.12.1 Sistemic Scotland Limited Company Summary
7.12.2 Sistemic Scotland Limited Business Overview
7.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.12.5 Sistemic Scotland Limited Key News & Latest Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Company Summary
7.13.2 Thermo Fisher Scientific Inc. Business Overview
7.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.13.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.14 Vigene Biosciences, Inc.
7.14.1 Vigene Biosciences, Inc. Company Summary
7.14.2 Vigene Biosciences, Inc. Business Overview
7.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.14.5 Vigene Biosciences, Inc. Key News & Latest Developments
7.15 WuXi AppTec
7.15.1 WuXi AppTec Company Summary
7.15.2 WuXi AppTec Business Overview
7.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Major Product Offerings
7.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue in Global Market (2018-2023)
7.15.5 WuXi AppTec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell and Gene Therapy Manufacturing QC Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Manufacturing QC Market Drivers in Global Market
Table 3. Cell and Gene Therapy Manufacturing QC Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Manufacturing QC in Global Market
Table 5. Top Cell and Gene Therapy Manufacturing QC Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell and Gene Therapy Manufacturing QC Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell and Gene Therapy Manufacturing QC Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing QC Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing QC Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell and Gene Therapy Manufacturing QC Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2024-2030
Table 30. Bio-Techne Corporation Company Summary
Table 31. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offerings
Table 32. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 33. Bio-Techne Corporation Key News & Latest Developments
Table 34. BioMerieux SA Company Summary
Table 35. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offerings
Table 36. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 37. BioMerieux SA Key News & Latest Developments
Table 38. Catalent, Inc. Company Summary
Table 39. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 40. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 41. Catalent, Inc. Key News & Latest Developments
Table 42. Charles River Laboratories International Inc. Company Summary
Table 43. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 44. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 45. Charles River Laboratories International Inc. Key News & Latest Developments
Table 46. Eurofins Scientific SE Company Summary
Table 47. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offerings
Table 48. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 49. Eurofins Scientific SE Key News & Latest Developments
Table 50. F. Hoffmann-La Roche Ltd Company Summary
Table 51. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offerings
Table 52. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 53. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 54. Intertek Group plc Company Summary
Table 55. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offerings
Table 56. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 57. Intertek Group plc Key News & Latest Developments
Table 58. Lonza Group AG Company Summary
Table 59. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offerings
Table 60. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 61. Lonza Group AG Key News & Latest Developments
Table 62. Merck KGaA Company Summary
Table 63. Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offerings
Table 64. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 65. Merck KGaA Key News & Latest Developments
Table 66. Sartorius AG Company Summary
Table 67. Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offerings
Table 68. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 69. Sartorius AG Key News & Latest Developments
Table 70. SGS S.A. Company Summary
Table 71. SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 72. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 73. SGS S.A. Key News & Latest Developments
Table 74. Sistemic Scotland Limited Company Summary
Table 75. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offerings
Table 76. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 77. Sistemic Scotland Limited Key News & Latest Developments
Table 78. Thermo Fisher Scientific Inc. Company Summary
Table 79. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 80. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 81. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 82. Vigene Biosciences, Inc. Company Summary
Table 83. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offerings
Table 84. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 85. Vigene Biosciences, Inc. Key News & Latest Developments
Table 86. WuXi AppTec Company Summary
Table 87. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offerings
Table 88. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue (US$, Mn) & (2018-2023)
Table 89. WuXi AppTec Key News & Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing QC Segment by Type in 2022
Figure 2. Cell and Gene Therapy Manufacturing QC Segment by Application in 2022
Figure 3. Global Cell and Gene Therapy Manufacturing QC Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Manufacturing QC Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Manufacturing QC Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2022
Figure 8. By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 16. US Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 20. Germany Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 21. France Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 28. China Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 32. India Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 34. Brazil Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing QC Revenue Market Share, 2018-2030
Figure 37. Turkey Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cell and Gene Therapy Manufacturing QC Revenue, (US$, Mn), 2018-2030
Figure 41. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
